Chapter 1. HLA TYPING FOR TRANSPLANT MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. HLA TYPING FOR TRANSPLANT MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-111 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. HLA TYPING FOR TRANSPLANT MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. HLA TYPING FOR TRANSPLANT MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. HLA TYPING FOR TRANSPLANT MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. HLA TYPING FOR TRANSPLANT MARKET– By Technology

6.1. Non-Molecular Assays

       6.1.1. Mixed Lymphocyte Culture (MLC) Assays

       6.1.2. Serological Assays

6.2. Molecular Assays

       6.2.1. Sequencing Based

              6.2.1.1. Next-Generation Sequencing (NGS)

              6.2.1.2. Sanger Sequencing

       6.2.2. PCR Based

              6.2.2.1. Sequence-Specific Oligonucleotide (SSO)-PCR

              6.2.2.2. Sequence-Specific Primer (SSP)-PCR

Chapter 7. HLA TYPING FOR TRANSPLANT MARKET– By Application

7.1. Research

7.2. Diagnostic

Chapter 8. HLA TYPING FOR TRANSPLANT MARKET– By End User

8.1. Commercial Service Providers

8.2. Research Laboratories and Academic Institutes

8.3. Hospitals and Transplant Centers

Chapter 9. HLA TYPING FOR TRANSPLANT MARKET– By Products and Services

9.1. Reagents and Consumables

9.2. Software and Services

9.3. Instruments

Chapter 10. HLA TYPING FOR TRANSPLANT MARKET– By Region

10.1. North America

10.2. Europe

10.3. The Asia Pacific

10.4. Latin America

10.5. Middle-East and Africa

Chapter 11. HLA TYPING FOR TRANSPLANT MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

11.1. Company 1

11.2. Company 2

11.3. Company 3

11.4. Company 4

11.5. Company 5

11.6. Company 6

11.7. Company 7

11.8. Company 8

11.9. Company 9

11.10. Company 10

Download Sample